• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    BioNTech SE - American Depositary Shares (NQ:BNTX)

    96.78 +1.58 (+1.66%)
    Streaming Delayed Price Updated: 10:42 AM EST, Jan 2, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 275,223
    Open 96.42
    Bid (Size) 96.67 (300)
    Ask (Size) 96.80 (400)
    Prev. Close 95.20
    Today's Range 96.19 - 97.78
    52wk Range 81.20 - 129.27
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Genmab Stock Slips After Discontinuing Further Development Of Cancer Drug Developed With BioNTech ↗
    The company has decided to concentrate on cancer therapies Epkinly, Petosemtamab and Rina‑S, which are in late-stage development. 
    Via Stocktwits
    Topics Supply Chain
    News headline image
    Moderna (MRNA) Deep-Dive: Navigating the 7.5% Year-End Slide and the Path to a 2028 Recovery
    As of December 24, 2025, Moderna, Inc. (Nasdaq: MRNA) finds itself at a pivotal crossroads in its corporate evolution. Once the definitive success story of the pandemic era, the Cambridge-based... 
    Via PredictStreet
    Topics Initial Public Offering

    Performance

    YTD
    N/A
    N/A
    1 Month
    +0.7%
    +0.7%
    3 Month
    -7.4%
    -7.4%
    6 Month
    -12.0%
    -12.0%
    1 Year
    -16.1%
    -16.1%

    More News

    Read More
    News headline image
    The Pfizer Pivot: A Deep-Dive into PFE’s 2025 Financial Recovery and Strategic Rebirth
    Via PredictStreet
    Topics Economy Intellectual Property
    News headline image
    Earnings Scheduled For November 3, 2025 ↗
    Via Benzinga
    News headline image
    Moderna (MRNA): The “Act 2” of an mRNA Pioneer – A 2025 Deep Dive
    Via PredictStreet
    Topics Earnings Initial Public Offering Intellectual Property
    News headline image
    BioNTech Closes Acquisition of CureVac N.V. Including Subsequent Offering Period to Strengthen its Unique Position in the mRNA Field
    From BioNTech SE
    Via GlobeNewswire
    News headline image
    Pfizer's Muted 2026 Outlook Sends Ripples Through Pharmaceutical Sector
    Via MarketMinute
    Topics Intellectual Property
    News headline image
    BioNTech and Bristol Myers Squibb Present First Global Phase 2 Data for PD-L1xVEGF-A Bispecific Antibody Pumitamig Showing Encouraging Efficacy in Advanced Triple-Negative Breast Cancer
    From BioNTech SE
    Via GlobeNewswire
    News headline image
    BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer
    From BioNTech SE
    Via GlobeNewswire
    News headline image
    BioNTech Achieves Minimum Condition in CureVac Exchange Offer
    From BioNTech SE
    Via GlobeNewswire
    News headline image
    Moderna, BioNTech Slammed After FDA Links Covid Shots To 10 Deaths ↗
    Via Investor's Business Daily
    Topics Death
    News headline image
    2 Top Dividend Stocks to Buy and Hold ↗
    Via The Motley Fool
    Topics Artificial Intelligence Intellectual Property
    News headline image
    BioNTech (BNTX) Q3 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration
    From BioNTech SE
    Via GlobeNewswire
    News headline image
    Pfizer Seeks To Exit BioNTech Investment After Lucrative Covid Vaccine Run ↗
    Via Benzinga
    News headline image
    BioNTech Says Collaboration With Pfizer Going Strong After Report Indicated US Pharma Giant Considering Stake Sale In The German Company ↗
    Via Stocktwits
    News headline image
    BioNTech Sees Higher 2025 Sales Driven By Bristol Myers Partnership ↗
    Via Benzinga
    News headline image
    BioNTech SE (NASDAQ:BNTX) Reports Mixed Q3 2025 Results with Major Revenue Beat and Quarterly Loss ↗
    Via Chartmill
    News headline image
    BioNTech Announces Third Quarter 2025 Financial Results and Corporate Update
    From BioNTech SE
    Via GlobeNewswire
    News headline image
    BioNTech to Host Innovation Series R&D Day on November 11, 2025
    From BioNTech SE
    Via GlobeNewswire
    News headline image
    Healthcare Sector Navigates Volatile Waters as S&P 500 Closes: A Deep Dive into Key Market Drivers
    Via MarketMinute
    Topics Artificial Intelligence Economy Intellectual Property
    News headline image
    BioNTech to Report Third Quarter 2025 Financial Results and Corporate Update on November 3, 2025
    From BioNTech SE
    Via GlobeNewswire
    News headline image
    2 Unstoppable Dividend Stocks Yielding More Than 4% That Income-Seeking Investors Will Want to Buy in November and Hold Forever ↗
    Via The Motley Fool
    Topics Government Intellectual Property World Trade
    News headline image
    BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V.
    From BioNTech SE
    Via GlobeNewswire
    News headline image
    Beyond The Numbers: 7 Analysts Discuss BioNTech Stock ↗
    Via Benzinga

    Frequently Asked Questions

    Is BioNTech SE - American Depositary Shares publicly traded?
    Yes, BioNTech SE - American Depositary Shares is publicly traded.
    What exchange does BioNTech SE - American Depositary Shares trade on?
    BioNTech SE - American Depositary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for BioNTech SE - American Depositary Shares?
    The ticker symbol for BioNTech SE - American Depositary Shares is BNTX on the Nasdaq Stock Market
    What is the current price of BioNTech SE - American Depositary Shares?
    The current price of BioNTech SE - American Depositary Shares is 96.78
    When was BioNTech SE - American Depositary Shares last traded?
    The last trade of BioNTech SE - American Depositary Shares was at 01/02/26 10:42 AM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.